Subscribe to our newsletter

SPHERES: Neuromyelitis Optica Spectrum Disorder (NMOSD) Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
STUDY VISITS
0 +
PATIENTS
0 +
SITES
0 +
MDS
0 +
STATES
0 +

Participating Sites

CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
LEARN MORE

Outcome measures in the CorEvitas NMOSD Registry

Among the variables we collect, some of the key outcome measures to inform your research include:

Disease Characteristics

  • Primary Diagnosis
  • Year of onset and diagnosis​ of NMOSD
  • Year of onset and diagnosis​ of NMOSD
  • Year of onset and diagnosis​ of NMOSD
  • Year of onset and diagnosis​ of NMOSD

Calculated Measures

  • Harvey-Bradshaw Index (Crohn’s disease)
  • Simple Clinical Colitis Activity Index (SCCAI) (Ulcerative colitis)
  • Mayo Score (partial) (Ulcerative colitis)
  • Simple Endoscopic Score (SES-CD) (Crohn’s disease, if endoscopic score provided)
  • Mayo Severity Index (if flexible proctosigmoidoscopy findings provided)

Patient Reported Outcomes

  • PROMIS – Anxiety, Depression, Fatigue, Sleep Disturbance, Pain Interference
  • Work Productivity and Activity Impairment (WPAI)

Our Publications

MANUSCRIPTS AND ABSTRACTS

Other Registries

Question about a registry?

Contact Us